http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_74e5eb2ebb437f6e0c757a595e44d340
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Tang |
| name | Shenghui Tang |
| given-name | Shenghui |
| organization-name | Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA US Food and Drug Administration, White Oak, MD 2Office of Biostatistics, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland. 2Office of Biostatistics, U.S. Food and Drug Administration, Silver Spring, Maryland. US Food and Drug Administration, Silver Spring, MD Office of Hematology and Oncology Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA 4Biostatistics, and Office of Hematology and Oncology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA 1Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland. Department of Medicine, Medical Statistics Section, University of Alabama at Birmingham, Birmingham, Alabama Center for Drug Evaluation and Research U.S. Food and Drug Administration, Silver Spring, Maryland, USA Departments of Medicine Office of Biostatistics, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland. Chana Weinstock, MD; Laura L. Fernandes, PhD; Marc Theoret, MD; Shenghui Tang, PhD; Rajeshwari Sridhara, PhD; Julia A. Beaver, MD; and Richard Pazdur, MD, US Food and Drug Administration, Silver Spring, MD US Food and Drug Administration, Silver Spring, Maryland Center for Drug Evaluation and Research, U.S. Food and Drug Administration, White Oak, Maryland. Lung Health Center; School of Health Related Professions; School of Medicine; Comprehensive Cancer Center, Division of Biostatistics, University of Alabama at Birmingham; Department of Biostatistics, School of Public Health; and Alabama Department of Public Health, Division of Tuberculosis Control, Birmingham, Alabama Center for Drug Evaluation and Research, U.S. Food and Drug, Administration, Silver Spring, Maryland. Authors' Affiliation: Division of Drug Oncology Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland 1US Food and Drug Administration, Center for Drug Evaluation and Research, Office of Biostatistics, Silver Spring, Maryland. Authors' Affiliation: Office of Hematology and Oncology Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, White Oak, Maryland Office of Oncology Drug Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Springs, Maryland, USA 1Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration, Silver Spring, Maryland. Authors' Affiliation: Center for Drug Evaluation and Research, U.S. Food and Drug Administration, White Oak, Maryland Center for Drug Evaluation and Research, US Food and Drug Administration , Silver Spring, MD , USA All authors: Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD. Authors' Affiliation: Office of Oncology Drug Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland 2Office of Biostatistics, FDA, Silver Spring, Maryland. Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland Office of Biostatistics, Center for Drug Evaluation and Research, FDA, MD, USA Authors' Affiliations: 1Office of Hematology and Oncology Products, Office of New Drugs, 2Office of Biostatistics, 3Office of Clinical Pharmacology, and 4Office of New Drug Quality Assessment, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland Center for Drug Evaluation and Research, U.S. Food and Drug, Administration, White Oak, Maryland. U.S. Food and Drug Administration, White Oak, Maryland. Authors' Affiliations: 1CDER/OTS/OB/DBV, and 2CDER/OND/OHOP/DOP-1, U.S. Food and Drug Administration, Silver Spring, Maryland Authors' Affiliations: 1Office of Hematology and Oncology Products, 2Office of Biostatistics, 3Office of Clinical Pharmacology, and 4Office of Pharmaceutical Science, Office of New Drug Quality Assessment, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland Center for Drug Evaluation and Research, US Food and Drug Administration, White Oak, Maryland All authors: Office of Hematology and Oncology Products, Center for Drug Evaluation and Research, US Food and Drug Administration, White Oak, MD. |
Incoming Links
Total number of triples: 130.